https://www.bloomberg.com/news/articles/2017-06-04/life-in-womb-death-in-cancer-this-enzyme-is-new-research-focus
http://www.military-technologies.net/2017/06/04/new-monotherapy-data-for-mercks-keytruda-pembrolizumab-in-heavily-pre-treated-patients-with-advanced-gastric-cancer-to-be-presented-at-2017-asco-annual-meeting/
http://www.military-technologies.net/2017/06/04/f-star-expands-its-relationship-with-merck-through-a-new-strategic-collaboration-to-develop-bispecific-antibodies-in-immuno-oncology/
http://www.military-technologies.net/2017/06/04/merck-kgaa-darmstadt-germany-strengthens-immuno-oncology-portfolio-through-expansion-of-f-star-collaboration-including-lag-3pd-l1-bispecific-antibody/
http://www.prnewswire.com/news-releases/merck-kgaa-darmstadt-germany-strengthens-immuno-oncology-portfolio-through-expansion-of-f-star-collaboration-including-lag-3pd-l1-bispecific-antibody-300468333.html
http://www.finanzen.at/nachrichten/aktien/Further-Study-of-Combination-of-Eisais-Lenvatinib-and-Mercks-Pembrolizumab-in-Previously-Treated-Patients-with-Metastatic-Endometrial-Cancer-Supported-by-Interim-Analysis-of-Ongoing-Phase-1b-2-Trial-1002065395
http://www.finanzen.ch/nachrichten/aktien/Further-Study-of-Combination-of-Eisais-Lenvatinib-and-Mercks-Pembrolizumab-in-Previously-Treated-Patients-with-Metastatic-Endometrial-Cancer-Supported-by-Interim-Analysis-of-Ongoing-Phase-1b-2-Trial-1002065395
http://www.military-technologies.net/2017/06/03/further-study-of-combination-of-eisais-lenvatinib-and-mercks-pembrolizumab-in-previously-treated-patients-with-metastatic-endometrial-cancer-supported-by-interim-analysis-of-ongoing-phase-1b2-tri/
http://www.military-technologies.net/2017/06/03/combination-of-incytes-epacadostat-plus-mercks-keytruda-pembrolizumab-demonstrates-activity-in-clinical-trial-of-patients-with-advanced-non-small-cell-lung-cancer-nsclc-2/
http://www.businesswire.com/news/home/20170603005028/en/Combination-Incyte%E2%80%99s-Epacadostat-Merck%E2%80%99s-KEYTRUDA%C2%AE-pembrolizumab-Demonstrates/?feedref=JjAwJuNHiystnCoBq_hl-YorNIXXeJUidDamMzBr2lUAKMtEGtRj-e8KfM-o9q9qrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3miEx88JtThI8BEp2XznrHLRzAC4_rGwOLNoA4bcgbFNw==
http://www.military-technologies.net/2017/06/03/combination-of-incytes-epacadostat-plus-mercks-keytruda-pembrolizumab-demonstrates-activity-in-clinical-trial-of-patients-with-advanced-non-small-cell-lung-cancer-nsclc/
http://www.military-technologies.net/2017/06/03/new-data-show-durability-of-response-for-mercks-keytruda-pembrolizumab-in-advanced-microsatellite-instability-high-msi-h-or-mismatch-repair-deficient-dmmr-solid-tumors-regardless/
http://www.military-technologies.net/2017/06/03/longer-term-follow-up-data-with-mercks-keytruda-pembrolizumab-in-combination-with-pemetrexed-and-carboplatin-in-first-line-nonsquamous-metastatic-non-small-cell-lung-cancer-nsclc-to/
https://www.dailypolitical.com/2017/06/03/louisiana-state-employees-retirement-system-has-10-72-million-position-in-merck-co-inc-mrk.html
http://www.xconomy.com/national/2017/06/03/precision-steps-can-loxo-drug-help-broaden-use-of-cancer-dna-tests/
http://www.military-technologies.net/2017/06/03/combination-of-epacadostat-plus-keytruda-pembrolizumab-demonstrates-activity-in-clinical-trial-of-patients-with-advanced-non-small-cell-lung-cancer-nsclc/
http://www.stltoday.com/news/traffic/along-for-the-ride/along-for-the-ride-county-port-agency-helping-lambert-lure/article_a3f0064b-b995-5351-ab0a-055cab11de61.html
http://www.thejournal.ie/week-in-numbers-152-3416161-Jun2017/
http://timesofindia.indiatimes.com/business/international-business/loxos-targeted-drug-helps-variety-of-advanced-cancers-in-small-study/articleshow/58975935.cms
http://www.channelnewsasia.com/news/health/loxo-s-targeted-drug-helps-variety-of-advanced-cancers-in-small-study-8909766
http://www.dailymail.co.uk/~/article-4568706/index.html
http://www.military-technologies.net/2017/06/03/dynavax-presents-updated-data-for-sd-101-in-combination-with-keytrudar-pembrolizumab-highlighting-an-orr-in-7-out-of-7-patients-naive-to-an-anti-pd-1-or-anti-pd-l1-therapy-3/
http://www.xconomy.com/boston/2017/06/02/mersana-plans-ipo-to-finance-clinical-trials-for-breast-cancer-drug/
https://www.bloomberg.com/news/articles/2017-06-03/cancer-drug-targeting-rare-mutation-works-across-tumor-types
http://www.emailwire.com/release/392999-Human-Microbiome-Market-by-Disease-Data-Validation-Analysis-and-Forecast-2022.html
http://www.marketwatch.com/story/immunotherapy-drug-effective-for-metastatic-triple-negative-breast-cancer-2017-06-03
